Andrew Bathgate

2.9k citations

35 papers · 1.1k indexed · h-index 18

Impact in

Hepatology top 1%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatitis C virus research
Transplantation top 5%

Papers in ⓘ

Hepatology 27
- Liver Disease and Transplantation 16
- Hepatitis C virus research 11
- Liver Diseases and Immunity 6
- Hepatocellular Carcinoma Treatment and Prognosis 5
Epidemiology 18
- Liver Disease Diagnosis and Treatment 16
- Hepatitis B Virus Studies 4

Co-authors: Peter Hayes (14 shared papers)Graeme Alexander (4 shared papers)James Neuberger (5 shared papers)George Mells (5 shared papers)Andrew K. Burroughs (3 shared papers)Darren B. Day (4 shared papers)Richard Sandford (4 shared papers)Samantha Ducker (3 shared papers)
Journals: Journal of Hepatology (4 papers)Alimentary Pharmacology & Therapeutics (3 papers)Journal of Viral Hepatitis (3 papers)Transplantation (2 papers)European Journal of Gastroenterology & Hepatology (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Andrew Bathgate

35 papers receiving 1.0k citations

Peers

Countries citing papers authored by Andrew Bathgate

Since Specialization

Citations

This map shows the geographic impact of Andrew Bathgate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bathgate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bathgate more than expected).

Fields of papers citing papers by Andrew Bathgate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bathgate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bathgate. The network helps show where Andrew Bathgate may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Bathgate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Bathgate Line = papers co-authored together Andrew Bathgate links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis Nature Genetics ·Jimmy Z. Liu, Mohamed A. Almarri, Daniel J. Gaffney, George Mells, Luke Jostins, Heather J. Cordell, Samantha Ducker, Darren B. Day, Michael A. Heneghan, James Neuberger, Peter T. Donaldson, Andrew Bathgate, Andrew K. Burroughs, Mervyn H. Davies, D. I. Jones, Graeme Alexander, Jeffrey C. Barrett, Richard Sandford, Carl A. Anderson	2012	180
2	Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study Hepatology ·George Mells, Greta Pells, Julia L. Newton, Andrew Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James Neuberger, Darren B. Day, Samantha Ducker, Richard Sandford, Graeme Alexander, David Jones	2013	157
3	A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES) program Journal of Cardiovascular Magnetic Resonance ·Gabriella Captur, Peter Gatehouse, Kathryn E. Keenan, Friso G. Heslinga, Ruediger Bruehl, Marcel Prothmann, Martin J. Graves, Richard J. Eames, Camilla Torlasco, Giulia Benedetti, Jacqueline Donovan, Bernd Ittermann, Redha Boubertakh, Andrew Bathgate, Celine Royet, Wenjie Pang, Reza Nezafat, Michael Salerno, Peter Kellman, James Moon	2016	132
4	THE EFFECT OF POLYMORPHISMS IN TUMOR NECROSIS FACTOR-??, INTERLEUKIN-10, AND TRANSFORMING GROWTH FACTOR-??1 GENES IN ACUTE HEPATIC ALLOGRAFT REJECTION Transplantation ·Andrew Bathgate, Vera Pravica, Chris Perrey, George Therapondos, John Plevris, Peter Hayes, Ian V. Hutchinson	2000	85
5	The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis Alimentary Pharmacology & Therapeutics ·Jessica Dyson, Nina Wilkinson, Laura Jopson, George Mells, Andrew Bathgate, M. Heneghan, James Neuberger, Gideon M. Hirschfield, SJ Ducker, Richard Sandford, Graeme Alexander, Deborah Stocken, Diana Jones	2016	56
6	The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort Journal of Hepatology ·Greta Pells, George Mells, Marco Carbone, Julia L. Newton, Andrew Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James Neuberger, Darren B. Day, Samantha Ducker, Richard Sandford, Graeme Alexander, D. I. Jones	2013	46
7	Colorectal disease in liver allograft recipients – a clinicopathological study with follow-up European Journal of Gastroenterology & Hepatology ·Newton A C S Wong, Andrew Bathgate, Christopher Bellamy	2002	45
8	Polymorphisms in tumour necrosis factor α, interleukin-10 and transforming growth factor β1 genes and end-stage liver disease European Journal of Gastroenterology & Hepatology ·Andrew Bathgate, Vera Pravica, Chris Perrey, Peter Hayes, Ian V. Hutchinson	2000	40
9	C4d immunopositivity is uncommon in ABO‐compatible liver allografts, but correlates partially with lymphocytotoxic antibody status Histopathology ·Christopher Bellamy, Michael M Herriot, David J. Harrison, Andrew Bathgate	2007	38
10	Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population Toxicology Letters ·Newton A C S Wong, Frances Rae, Andrew Bathgate, Christopher A. Smith, David J. Harrison	2000	27
11	Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis Journal of Viral Hepatitis ·Scott McDonald, Kevin G. Pollock, Stephen T. Barclay, David Goldberg, Andrew Bathgate, Peter Bramley, John Dillon, Andrew Fraser, Hamish Innes, N. Kennedy, Judith Morris, April Went, Peter Hayes, Sharon Hutchinson	2019	27
12	Monoclonal antibodies as probes for detecting lipopolysaccharide expression on Escherichia coli from different growth conditions Journal of General Microbiology ·David Lee Nelson, Andrew Bathgate, Ian R. Poxton	1991	24
13	Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRI PLoS ONE ·Timothy G. St. Pierre, Michael J. House, Sander J. Bangma, Wenjie Pang, Andrew Bathgate, Eng K. Gan, Oyekoya T. Ayonrinde, Prithi S. Bhathal, Andrew D. Clouston, John K. Olynyk, Leon A. Adams	2016	23
14	Three-dimensional representation software as image enhancement tool in small-bowel capsule endoscopy: A feasibility study Digestive and Liver Disease ·Anastasios Koulaouzidis, Alexandros Karargyris, Emanuele Rondonotti, Colin Noble, Sarah Douglas, Efstratios Alexandridis, Ali M. Zahid, Andrew Bathgate, Ken Trimble, John Plevris	2013	23
15	Pretransplantation tumor necrosis factor-α production predicts acute rejection after liver transplantation Liver Transplantation ·Andrew Bathgate, Patricia Lee, Peter Hayes, Kenneth J. Simpson	2000	20
16	Portopulmonary hypertension: Still an appropriate consideration for liver transplantation? Liver Transplantation ·Suman Verma, Fiona Hand, Matthew J. Armstrong, M. De Vos, Douglas Thorburn, Terry Ling Te Pan, John Klinck, Rachel Westbrook, Georg Auzinger, Andrew Bathgate, Steven Masson, Andrew Holt, Diarmaid D. Houlihan, James Ferguson	2016	19
17	Liver transplant listing for hepatitis C‐associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct‐acting antiviral therapy Journal of Viral Hepatitis ·Arash Vaziri, Alexander Gimson, Kosh Agarwal, Mark Aldersley, Andrew Bathgate, Douglas MacDonald, Stuart McPherson, David Mutimer, William Gelson	2018	18
18	Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection JHEP Reports ·Hamish Innes, Peter Jepsen, Scott McDonald, John Dillon, Victoria Hamill, Alan C. Yeung, Jennifer Benselin, April Went, Andrew Fraser, Andrew Bathgate, M. Azim Ansari, Stephen T. Barclay, David Goldberg, Peter Hayes, Philip J. Johnson, Eleanor Barnes, William L. Irving, Sharon Hutchinson, Indra Neil Guha	2021	17
19	Review article: nucleoside analogues for the treatment of chronic hepatitis B Alimentary Pharmacology & Therapeutics ·Hazel M. Younger, Andrew Bathgate, Peter Hayes	2004	14
20	Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort Journal of Hepatology ·Hamish Innes, Stephen T. Barclay, P C Hayes, Andrew Fraser, John Dillon, Amie Stanley, Andrew Bathgate, Sarah E. McDonald, D. Goldberg, Heather Valerio, Richard Fox, N. Kennedy, P. Bramley, Sharon Hutchinson	2017	11

About Andrew Bathgate

Andrew Bathgate is a scholar working on Hepatology, Epidemiology, Surgery, Pulmonary and Respiratory Medicine and Transplantation, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (16 papers), Hepatitis C virus research (11 papers), Organ Transplantation Techniques and Outcomes (7 papers), Liver Diseases and Immunity (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Hepatitis B Virus Studies (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). The work is most often cited by research in Hepatology (609 citations), Transplantation (80 citations), Epidemiology (514 citations), Surgery (348 citations) and Gastroenterology (38 citations). Andrew Bathgate has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Peter Hayes, Graeme Alexander, James Neuberger, George Mells, Andrew K. Burroughs, Darren B. Day, Richard Sandford, Samantha Ducker, Michael A. Heneghan and Christopher Bellamy. Their work appears in journals such as Journal of Hepatology, Alimentary Pharmacology & Therapeutics, Journal of Viral Hepatitis, Transplantation and European Journal of Gastroenterology & Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact